|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
102 a.a.
|
 |
|
|
|
|
|
|
|
212 a.a.
|
 |
|
|
|
|
|
|
|
219 a.a.
|
 |
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Unknown function/immune system
|
 |
|
Title:
|
 |
Ovine recombinant prp(114-234), vrq variant in complex with the fab of the vrq14 antibody
|
|
Structure:
|
 |
Prion protein. Chain: a. Fragment: vrq variant, residues 127-228. Synonym: ovprp. Engineered: yes. Vrq14 fab heavy chain. Chain: b. Fragment: vrq14 fab fragment. Engineered: yes.
|
|
Source:
|
 |
Ovis aries. Sheep. Organism_taxid: 9940. Gene: prnp sheep vrq variant. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008. Mus musculus. House mouse. Organism_taxid: 10090.
|
|
Biol. unit:
|
 |
Trimer (from
)
|
|
Resolution:
|
 |
|
2.55Å
|
R-factor:
|
0.214
|
R-free:
|
0.268
|
|
|
Authors:
|
 |
F.Eghiaian,J.Grosclaude,P.Debey,B.Doublet,E.Treguer,H.Rezaei, M.Knossow
|
Key ref:
|
 |
F.Eghiaian
et al.
(2004).
Insight into the PrPC-->PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants.
Proc Natl Acad Sci U S A,
101,
10254-10259.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
17-Jun-04
|
Release date:
|
06-Jul-04
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P23907
(PRIO_SHEEP) -
Major prion protein from Ovis aries
|
|
|
|
Seq: Struc:
|
 |
 |
 |
256 a.a.
102 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
101:10254-10259
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
Insight into the PrPC-->PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants.
|
|
F.Eghiaian,
J.Grosclaude,
S.Lesceu,
P.Debey,
B.Doublet,
E.Tréguer,
H.Rezaei,
M.Knossow.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Prion diseases are associated with the conversion of the alpha-helix rich prion
protein (PrPC) into a beta-structure-rich insoluble conformer (PrPSc) that is
thought to be infectious. The mechanism for the PrPC-->PrPSc conversion and its
relationship with the pathological effects of prion diseases are poorly
understood, partly because of our limited knowledge of the structure of PrPSc.
In particular, the way in which mutations in the PRNP gene yield variants that
confer different susceptibilities to disease needs to be clarified. We report
here the 2.5-A-resolution crystal structures of three scrapie-susceptibility
ovine PrP variants complexed with an antibody that binds to PrPC and to PrPSc;
they identify two important features of the PrPC-->PrPSc conversion. First, the
epitope of the antibody mainly consists of the last two turns of ovine PrP
second alpha-helix. We show that this is a structural invariant in the
PrPC-->PrPSc conversion; taken together with biochemical data, this leads to a
model of the conformational change in which the two PrPC C-terminal
alpha-helices are conserved in PrPSc, whereas secondary structure changes are
located in the N-terminal alpha-helix. Second, comparison of the structures of
scrapie-sensitivity variants defines local changes in distant parts of the
protein that account for the observed differences of PrPC stability, resistant
variants being destabilized compared with sensitive ones. Additive contributions
of these sensitivity-modulating mutations to resistance suggest a possible
causal relationship between scrapie resistance and lowered stability of the PrP
protein.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Structure of the OvPrP C-terminal domain. (A) The
OvPrP fold and the scrapie-sensitivity-associated mutations.
Side chains of scrapie-sensitivity-related residues are
represented as green ball-and-stick models in the OvPrP
structure. (B Left) Structure of the huPrP crystallographic
dimer (27) (one monomer is shown in salmon red, and the other is
shown in blue). (B Right) Superimposition of the x-ray
structures of OvPrP (this work, red) and of a huPrP domain
(blue) constituted by the H3 helix of one monomer and of the
rest of the sequence of the other monomer.
|
 |
Figure 2.
Fig. 2. Structural consequences of
scrapie-sensitivity-related mutations. The blue grid corresponds
to the 1.0- level contour of the
2Fo - Fc omit map. Maps are calculated by using data in the
15.0- to 2.5-Å-resolution range for the ARQ and VRQ
variants and the 15.0- to 2.8-Å-resolution range for the
ARR variant. Hydrogen bonds are displayed as dashed lines, and
distances of the atoms involved are reported. (Upper) A136V. The
Fo[VRQ] - Fo[ARQ] difference map, represented as red and green
grids (contour levels: -5.0 and 5.0 ,
respectively) is superimposed on the ARQ 2Fo - Fc omit map.
(Lower) Q171R.
|
 |
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
B.Sweeting,
M.Q.Khan,
A.Chakrabartty,
and
E.F.Pai
(2010).
Structural factors underlying the species barrier and susceptibility to infection in prion disease.
|
| |
Biochem Cell Biol,
88,
195-202.
|
 |
|
|
|
|
 |
C.A.Tabrett,
C.F.Harrison,
B.Schmidt,
S.A.Bellingham,
T.Hardy,
Y.H.Sanejouand,
A.F.Hill,
and
P.J.Hogg
(2010).
Changing the solvent accessibility of the prion protein disulfide bond markedly influences its trafficking and effect on cell function.
|
| |
Biochem J,
428,
169-182.
|
 |
|
|
|
|
 |
J.Gaspersic,
I.Hafner-Bratkovic,
M.Stephan,
P.Veranic,
M.Bencina,
I.Vorberg,
and
R.Jerala
(2010).
Tetracysteine-tagged prion protein allows discrimination between the native and converted forms.
|
| |
FEBS J,
277,
2038-2050.
|
 |
|
|
|
|
 |
S.Lee,
L.Antony,
R.Hartmann,
K.J.Knaus,
K.Surewicz,
W.K.Surewicz,
and
V.C.Yee
(2010).
Conformational diversity in prion protein variants influences intermolecular beta-sheet formation.
|
| |
EMBO J,
29,
251-262.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Steunou,
J.F.Chich,
H.Rezaei,
and
J.Vidic
(2010).
Biosensing of lipid-prion interactions: insights on charge effect, Cu(II)-ions binding and prion oligomerization.
|
| |
Biosens Bioelectron,
26,
1399-1406.
|
 |
|
|
|
|
 |
C.Y.Tseng,
C.P.Yu,
and
H.C.Lee
(2009).
Integrity of H1 helix in prion protein revealed by molecular dynamic simulations to be especially vulnerable to changes in the relative orientation of H1 and its S1 flank.
|
| |
Eur Biophys J,
38,
601-611.
|
 |
|
|
|
|
 |
F.Guerrieri,
V.Minicozzi,
S.Morante,
G.Rossi,
S.Furlan,
and
G.La Penna
(2009).
Modeling the interplay of glycine protonation and multiple histidine binding of copper in the prion protein octarepeat subdomains.
|
| |
J Biol Inorg Chem,
14,
361-374.
|
 |
|
|
|
|
 |
H.Wille,
M.Shanmugam,
M.Murugesu,
J.Ollesch,
G.Stubbs,
J.R.Long,
J.G.Safar,
and
S.B.Prusiner
(2009).
Surface charge of polyoxometalates modulates polymerization of the scrapie prion protein.
|
| |
Proc Natl Acad Sci U S A,
106,
3740-3745.
|
 |
|
|
|
|
 |
N.Kowalsman,
and
M.Eisenstein
(2009).
Combining interface core and whole interface descriptors in postscan processing of protein-protein docking models.
|
| |
Proteins,
77,
297-318.
|
 |
|
|
|
|
 |
S.V.Antonyuk,
C.R.Trevitt,
R.W.Strange,
G.S.Jackson,
D.Sangar,
M.Batchelor,
S.Cooper,
C.Fraser,
S.Jones,
T.Georgiou,
A.Khalili-Shirazi,
A.R.Clarke,
S.S.Hasnain,
and
J.Collinge
(2009).
Crystal structure of human prion protein bound to a therapeutic antibody.
|
| |
Proc Natl Acad Sci U S A,
106,
2554-2558.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.M.Thackray,
L.Hopkins,
J.Spiropoulos,
and
R.Bujdoso
(2008).
Molecular and transmission characteristics of primary-passaged ovine scrapie isolates in conventional and ovine PrP transgenic mice.
|
| |
J Virol,
82,
11197-11207.
|
 |
|
|
|
|
 |
K.D.Kedarisetti,
S.Dick,
and
L.Kurgan
(2008).
Searching for Factors that Distinguish Disease-Prone and Disease-Resistant Prions via Sequence Analysis.
|
| |
Bioinform Biol Insights,
2,
133-144.
|
 |
|
|
|
|
 |
L.Ronga,
P.Palladino,
G.Saviano,
T.Tancredi,
E.Benedetti,
R.Ragone,
and
F.Rossi
(2008).
Structural characterization of a neurotoxic threonine-rich peptide corresponding to the human prion protein alpha 2-helical 180-195 segment, and comparison with full-length alpha 2-helix-derived peptides.
|
| |
J Pept Sci,
14,
1096-1102.
|
 |
|
|
|
|
 |
S.Noinville,
J.F.Chich,
and
H.Rezaei
(2008).
Misfolding of the prion protein: linking biophysical and biological approaches.
|
| |
Vet Res,
39,
48.
|
 |
|
|
|
|
 |
V.Gayrard,
N.Picard-Hagen,
C.Viguié,
E.Jeunesse,
G.Tabouret,
H.Rezaei,
and
P.L.Toutain
(2008).
Blood clearance of the prion protein introduced by intravenous route in sheep is influenced by host genetic and physiopathologic factors.
|
| |
Transfusion,
48,
609-619.
|
 |
|
|
|
|
 |
A.Pastore,
and
A.Zagari
(2007).
A structural overview of the vertebrate prion proteins.
|
| |
Prion,
1,
185-197.
|
 |
|
|
|
|
 |
C.W.Lennon,
H.D.Cox,
S.P.Hennelly,
S.J.Chelmo,
and
M.A.McGuirl
(2007).
Probing structural differences in prion protein isoforms by tyrosine nitration.
|
| |
Biochemistry,
46,
4850-4860.
|
 |
|
|
|
|
 |
D.Paludi,
S.Thellung,
K.Chiovitti,
A.Corsaro,
V.Villa,
C.Russo,
A.Ianieri,
U.Bertsch,
H.A.Kretzschmar,
A.Aceto,
and
T.Florio
(2007).
Different structural stability and toxicity of PrP(ARR) and PrP(ARQ) sheep prion protein variants.
|
| |
J Neurochem,
103,
2291-2300.
|
 |
|
|
|
|
 |
F.Eghiaian,
T.Daubenfeld,
Y.Quenet,
M.van Audenhaege,
A.P.Bouin,
G.van der Rest,
J.Grosclaude,
and
H.Rezaei
(2007).
Diversity in prion protein oligomerization pathways results from domain expansion as revealed by hydrogen/deuterium exchange and disulfide linkage.
|
| |
Proc Natl Acad Sci U S A,
104,
7414-7419.
|
 |
|
|
|
|
 |
G.L.Millhauser
(2007).
Copper and the prion protein: methods, structures, function, and disease.
|
| |
Annu Rev Phys Chem,
58,
299-320.
|
 |
|
|
|
|
 |
M.Liu,
S.Yu,
J.Yang,
X.Yin,
and
D.Zhao
(2007).
RNA and CuCl2 induced conformational changes of the recombinant ovine prion protein.
|
| |
Mol Cell Biochem,
294,
197-203.
|
 |
|
|
|
|
 |
N.London,
and
O.Schueler-Furman
(2007).
Assessing the energy landscape of CAPRI targets by FunHunt.
|
| |
Proteins,
69,
809-815.
|
 |
|
|
|
|
 |
S.J.de Vries,
A.D.van Dijk,
M.Krzeminski,
M.van Dijk,
A.Thureau,
V.Hsu,
T.Wassenaar,
and
A.M.Bonvin
(2007).
HADDOCK versus HADDOCK: new features and performance of HADDOCK2.0 on the CAPRI targets.
|
| |
Proteins,
69,
726-733.
|
 |
|
|
|
|
 |
T.M.Cheng,
T.L.Blundell,
and
J.Fernandez-Recio
(2007).
pyDock: electrostatics and desolvation for effective scoring of rigid-body protein-protein docking.
|
| |
Proteins,
68,
503-515.
|
 |
|
|
|
|
 |
J.L.Whittingham,
Z.Youshang,
L.Záková,
E.J.Dodson,
J.P.Turkenburg,
J.Brange,
and
G.G.Dodson
(2006).
I222 crystal form of despentapeptide (B26-B30) insulin provides new insights into the properties of monomeric insulin.
|
| |
Acta Crystallogr D Biol Crystallogr,
62,
505-511.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
V.Granata,
P.Palladino,
B.Tizzano,
A.Negro,
R.Berisio,
and
A.Zagari
(2006).
The effect of the osmolyte trimethylamine N-oxide on the stability of the prion protein at low pH.
|
| |
Biopolymers,
82,
234-240.
|
 |
|
|
|
|
 |
A.D.van Dijk,
S.J.de Vries,
C.Dominguez,
H.Chen,
H.X.Zhou,
and
A.M.Bonvin
(2005).
Data-driven docking: HADDOCK's adventures in CAPRI.
|
| |
Proteins,
60,
232-238.
|
 |
|
|
|
|
 |
A.De Simone,
G.G.Dodson,
C.S.Verma,
A.Zagari,
and
F.Fraternali
(2005).
Prion and water: tight and dynamical hydration sites have a key role in structural stability.
|
| |
Proc Natl Acad Sci U S A,
102,
7535-7540.
|
 |
|
|
|
|
 |
C.J.Camacho
(2005).
Modeling side-chains using molecular dynamics improve recognition of binding region in CAPRI targets.
|
| |
Proteins,
60,
245-251.
|
 |
|
|
|
|
 |
C.Zhang,
S.Liu,
and
Y.Zhou
(2005).
Docking prediction using biological information, ZDOCK sampling technique, and clustering guided by the DFIRE statistical energy function.
|
| |
Proteins,
60,
314-318.
|
 |
|
|
|
|
 |
D.Law,
M.Hotchko,
and
L.Ten Eyck
(2005).
Progress in computation and amide hydrogen exchange for prediction of protein-protein complexes.
|
| |
Proteins,
60,
302-307.
|
 |
|
|
|
|
 |
E.Ben-Zeev,
N.Kowalsman,
A.Ben-Shimon,
D.Segal,
T.Atarot,
O.Noivirt,
T.Shay,
and
M.Eisenstein
(2005).
Docking to single-domain and multiple-domain proteins: old and new challenges.
|
| |
Proteins,
60,
195-201.
|
 |
|
|
|
|
 |
G.R.Smith,
P.W.Fitzjohn,
C.S.Page,
and
P.A.Bates
(2005).
Incorporation of flexibility into rigid-body docking: applications in rounds 3-5 of CAPRI.
|
| |
Proteins,
60,
263-268.
|
 |
|
|
|
|
 |
G.Terashi,
M.Takeda-Shitaka,
D.Takaya,
K.Komatsu,
and
H.Umeyama
(2005).
Searching for protein-protein interaction sites and docking by the methods of molecular dynamics, grid scoring, and the pairwise interaction potential of amino acid residues.
|
| |
Proteins,
60,
289-295.
|
 |
|
|
|
|
 |
H.Chen,
and
H.X.Zhou
(2005).
Prediction of interface residues in protein-protein complexes by a consensus neural network method: test against NMR data.
|
| |
Proteins,
61,
21-35.
|
 |
|
|
|
|
 |
J.Fernández-Recio,
R.Abagyan,
and
M.Totrov
(2005).
Improving CAPRI predictions: optimized desolvation for rigid-body docking.
|
| |
Proteins,
60,
308-313.
|
 |
|
|
|
|
 |
J.Janin
(2005).
Assessing predictions of protein-protein interaction: the CAPRI experiment.
|
| |
Protein Sci,
14,
278-283.
|
 |
|
|
|
|
 |
J.Janin
(2005).
The targets of CAPRI rounds 3-5.
|
| |
Proteins,
60,
170-175.
|
 |
|
|
|
|
 |
K.Wiehe,
B.Pierce,
J.Mintseris,
W.W.Tong,
R.Anderson,
R.Chen,
and
Z.Weng
(2005).
ZDOCK and RDOCK performance in CAPRI rounds 3, 4, and 5.
|
| |
Proteins,
60,
207-213.
|
 |
|
|
|
|
 |
M.D.Daily,
D.Masica,
A.Sivasubramanian,
S.Somarouthu,
and
J.J.Gray
(2005).
CAPRI rounds 3-5 reveal promising successes and future challenges for RosettaDock.
|
| |
Proteins,
60,
181-186.
|
 |
|
|
|
|
 |
M.Pastore,
S.S.Chin,
K.L.Bell,
Z.Dong,
Q.Yang,
L.Yang,
J.Yuan,
S.G.Chen,
P.Gambetti,
and
W.Q.Zou
(2005).
Creutzfeldt-Jakob disease (CJD) with a mutation at codon 148 of prion protein gene: relationship with sporadic CJD.
|
| |
Am J Pathol,
167,
1729-1738.
|
 |
|
|
|
|
 |
M.Zacharias
(2005).
ATTRACT: protein-protein docking in CAPRI using a reduced protein model.
|
| |
Proteins,
60,
252-256.
|
 |
|
|
|
|
 |
O.Schueler-Furman,
C.Wang,
and
D.Baker
(2005).
Progress in protein-protein docking: atomic resolution predictions in the CAPRI experiment using RosettaDock with an improved treatment of side-chain flexibility.
|
| |
Proteins,
60,
187-194.
|
 |
|
|
|
|
 |
P.Carter,
V.I.Lesk,
S.A.Islam,
and
M.J.Sternberg
(2005).
Protein-protein docking using 3D-Dock in rounds 3, 4, and 5 of CAPRI.
|
| |
Proteins,
60,
281-288.
|
 |
|
|
|
|
 |
R.Bujdoso,
D.F.Burke,
and
A.M.Thackray
(2005).
Structural differences between allelic variants of the ovine prion protein revealed by molecular dynamics simulations.
|
| |
Proteins,
61,
840-849.
|
 |
|
|
|
|
 |
R.L.Rich,
and
D.G.Myszka
(2005).
Survey of the year 2004 commercial optical biosensor literature.
|
| |
J Mol Recognit,
18,
431-478.
|
 |
|
|
|
|
 |
S.R.Comeau,
S.Vajda,
and
C.J.Camacho
(2005).
Performance of the first protein docking server ClusPro in CAPRI rounds 3-5.
|
| |
Proteins,
60,
239-244.
|
 |
|
|
|
|
 |
X.H.Ma,
C.H.Li,
L.Z.Shen,
X.Q.Gong,
W.Z.Chen,
and
C.X.Wang
(2005).
Biologically enhanced sampling geometric docking and backbone flexibility treatment with multiconformational superposition.
|
| |
Proteins,
60,
319-323.
|
 |
|
|
|
|
 |
Y.Inbar,
D.Schneidman-Duhovny,
I.Halperin,
A.Oron,
R.Nussinov,
and
H.J.Wolfson
(2005).
Approaching the CAPRI challenge with an efficient geometry-based docking.
|
| |
Proteins,
60,
217-223.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |
|